Kullback-leibler information approach to the optimum measurement point for bayesian estimation

When an appropriate parametric model and a prior distribution of its parameters are given to describe clinical time courses of a dynamic biological process, Bayesian approaches allow us to estimate the entire profiles from a few or even a single observation per subject. The goodness of the estimation depends on the measurement points at which the observations were made. The number of measurement points per subject is generally limited to one or two. The limited measurement points have to be selected carefully. This paper proposes an approach to the selection of the optimum measurement point for Bayesian estimations of clinical time courses. The selection is made among given candidates, based on the goodness of estimation evaluated by the Kullback-Leibler information. This information measures the discrepancy of an estimated time course from the true one specified by a given appropriate model. The proposed approach is applied to a pharmacokinetic analysis, which is a typical clinical example where the selection is required. The results of the present study strongly suggest that the proposed approach is applicable to pharmacokinetic data and has a wide range of clinical applications.     

A Note on Sample Size Determination for Akaike Information Criterion (AIC) Approach to Clinical Data Analysis

ABSTRACT

Because of its flexibility and usefulness, Akaike Information Criterion (AIC) has been widely used for clinical data analysis. In general, however, AIC is used without paying much attention to sample size. If sample sizes are not large enough, it is possible that the AIC approach does not lead us to the conclusions which we seek. This article focuses on the sample size determination for AIC approach to clinical data analysis. We consider a situation in which outcome variables are dichotomous and propose a method for sample size determination under this situation. The basic idea is also applicable to the situations in which outcome variables have more than two categories or outcome variables are continuous. We present simulation studies and an application to an actual clinical trial.